Evidence map›Paper›PMID 32749524›Full record

ReviewChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2020

Visual function tests including the role of optical coherence tomography in neurofibromatosis 1.

Daphna Mezad-Koursh, Anat Bachar Zipori, Dinah Zur, Lior Degabli, Meital Ben-Dov, Ainat Klein

Abstract readReview
PubMed Publisher
In one paragraph

Review in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Daphna Mezad-KourshDepartment of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. dmezad@gmail.com.ORCID http://orcid.org/0000-0002-7799-9022
Anat Bachar ZiporiDepartment of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Dinah ZurDepartment of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Lior DegabliDepartment of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Meital Ben-DovDepartment of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Ainat KleinDepartment of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Tel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optic pathway glioma (OPG) is a common and significant complication of neurofibromatosis 1 (NF-1) that might lead to vision loss. The main reason to treat OPG is to preserve vision. Tumor location along the visual pathway largely dictates the presenting signs and symptoms. Clinical ophthalmic evaluation is focused on optic nerve functions including evaluation of pupils' reaction to light, visual acuity, color vision, and visual field, as well as optic nerve appearance. An important relatively new ancillary test is optic coherence tomography (OCT) that measures the volume of retinal nerve fiber layer around the optic nerve and the ganglion cell layer-inner plexiform layer (GCL-IPL) of the macula, both proved to be strongly associated with losing vision in OPG. Accurate evaluation of vision functions plays a critical role in the decision of treatment. In this review, we describe the ophthalmological assessment including new biomarkers in clinical use. We also outline prognostic factors and current recommendations for surveillance and indications for treatment.

Indexed as

Neurofibromatosis 1Optic Nerve GliomaHumansNerve FibersRetinal Ganglion CellsTomography, Optical CoherenceOptical coherence tomography (OCT)Optic pathway gliomaVisual function

Identifiers

PMID32749524
OpenAlexW3047381795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.